143 related articles for article (PubMed ID: 36348678)
1. Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis.
Furukawa M; Okuyama K; Ninomiya K; Miyamoto T; Yato Y
Spine Surg Relat Res; 2022 Sep; 6(5):526-532. PubMed ID: 36348678
[TBL] [Abstract][Full Text] [Related]
2. Number of contiguous vertebral cross-links in the spine indicates bone formation: a cross-sectional study.
Furukawa M; Shibata R; Okuyama K
BMC Musculoskelet Disord; 2023 Sep; 24(1):736. PubMed ID: 37715167
[TBL] [Abstract][Full Text] [Related]
3. Maximum number of bone cross-linked vertebrae: an index for BMD in diffuse idiopathic skeletal hyperostosis.
Furukawa M; Okuyama K; Ninomiya K; Yato Y; Miyamoto T; Nakamura M; Matsumoto M
J Bone Miner Metab; 2022 Mar; 40(2):308-316. PubMed ID: 34845530
[TBL] [Abstract][Full Text] [Related]
4. Association of Continuous Vertebral Bone Bridges and Bone Mineral Density with the Fracture Risk in Patients with Diffuse Idiopathic Skeletal Hyperostosis.
Furukawa M; Okuyama K; Ninomiya K; Yato Y; Miyamoto T; Nakamura M; Matsumoto M
Asian Spine J; 2022 Feb; 16(1):75-81. PubMed ID: 33915617
[TBL] [Abstract][Full Text] [Related]
5. Increased Bone Mineral Density in Cervical or Thoracic Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Case-Control Study.
Sohn S; Chung CK; Han I; Park SB; Kim H
J Clin Densitom; 2018; 21(1):68-74. PubMed ID: 27712986
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population.
Wen Y; Li H; Zhang X; Liu P; Ma J; Zhang L; Zhang K; Song L
Front Endocrinol (Lausanne); 2021; 12():531904. PubMed ID: 34054717
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density changes over time in diffuse idiopathic skeletal hyperostosis of the thoracic spine.
Kuperus JS; Samsour L; Buckens CF; Oner FC; de Jong PA; Verlaan JJ
Bone; 2018 Jul; 112():90-96. PubMed ID: 29649655
[TBL] [Abstract][Full Text] [Related]
8. Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.
Tominaga A; Wada K; Kato Y; Nishi H; Terayama Y; Okazaki K
Osteoporos Int; 2021 Apr; 32(4):653-661. PubMed ID: 32979066
[TBL] [Abstract][Full Text] [Related]
9. Diffuse idiopathic skeletal hyperostosis (DISH): relation to vertebral fractures and bone density.
Diederichs G; Engelken F; Marshall LM; Peters K; Black DM; Issever AS; Barrett-Connor E; Orwoll E; Hamm B; Link TM;
Osteoporos Int; 2011 Jun; 22(6):1789-97. PubMed ID: 20882271
[TBL] [Abstract][Full Text] [Related]
10. Thick Skin on the Dorsal Spine in Osteoproliferative Disease: Ossification of the Posterior Longitudinal Ligament and Diffuse Idiopathic Skeletal Hyperostosis.
Morimoto T; Kobayashi T; Hirata H; Sugita K; Paholpak P; Tsukamoto M; Umeki S; Yoshihara T; Toda Y
Cureus; 2024 Jun; 16(6):e62235. PubMed ID: 38868545
[TBL] [Abstract][Full Text] [Related]
11. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
12. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
13. Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus.
Sahin G; Polat G; Bagis S; Milcan A; Erdogan C
J Womens Health (Larchmt); 2002 Nov; 11(9):801-4. PubMed ID: 12626079
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with bone metabolism in patients with cervical ossification of the posterior longitudinal ligament accompanied with diffuse idiopathic skeletal hyperostosis.
Horie S; Sawaji Y; Endo K; Suzuki H; Matsuoka Y; Nishimura H; Seki T; Yamamoto K
SICOT J; 2018; 4():7. PubMed ID: 29547116
[TBL] [Abstract][Full Text] [Related]
15. Bone Mineral Density and Physical Performance of Female Patients 27 Years or Longer after Surgery for Adolescent Idiopathic Scoliosis.
Akazawa T; Kotani T; Sakuma T; Katogi T; Minami S; Niki H; Torii Y; Morioka S; Orita S; Inage K; Fujimoto K; Shiga Y; Takahashi K; Ohtori S
Asian Spine J; 2017 Oct; 11(5):780-786. PubMed ID: 29093789
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and treatment of osteoporosis in patients undergoing total hip arthroplasty and the levels of biochemical markers of bone turnover.
Watanabe N; Miyatake K; Takada R; Ogawa T; Amano Y; Jinno T; Koga H; Yoshii T; Okawa A
Bone Joint Res; 2022 Dec; 11(12):873-880. PubMed ID: 36464500
[TBL] [Abstract][Full Text] [Related]
17. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
[TBL] [Abstract][Full Text] [Related]
18. Trabecular bone score and bone turnover markers in men with DISH: Data from the Camargo Cohort study.
Pini SF; Sgaramella GA; Pariente-Rodrigo E; Ramos-Barrón MC; Olmos-Martínez JM; Hernández-Hernández JL
Semin Arthritis Rheum; 2020 Dec; 50(6):1521-1524. PubMed ID: 32093967
[TBL] [Abstract][Full Text] [Related]
19. Teriparatide Improves Trabecular Osteoporosis but Simultaneously Promotes Ankylosis of the Spine in the Twy Mouse Model for Diffuse Idiopathic Skeletal Hyperostosis.
Hamano H; Takahata M; Ota M; Hiratsuka S; Shimizu T; Kameda Y; Iwasaki N
Calcif Tissue Int; 2016 Feb; 98(2):140-8. PubMed ID: 26463185
[TBL] [Abstract][Full Text] [Related]
20. Significant improvement of bone mineral density by denosumab without bisphosphonate pre-treatment in glucocorticoid-induced osteoporosis.
Suzuki T; Nakamura Y; Kato H
Mod Rheumatol; 2018 Sep; 28(5):885-889. PubMed ID: 29251033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
